Study on the regulatory mechanisms of mitochondrial biosynthesis by polyoxometalates

In recent years, polyoxometalates (POMs) have been extensively researched for their potential in treating diabetes, tumors, cancer, inflammation, and other diseases, both in vitro and in vivo. Their primary therapeutic mechanisms are related to the generation of reactive oxygen species (ROS), leadin...

Full description

Saved in:
Bibliographic Details
Main Authors: Shan Lei, Bingnian Chen, Li Wang, Jian Li
Format: Article
Language:English
Published: Tsinghua University Press 2025-03-01
Series:Polyoxometalates
Subjects:
Online Access:https://www.sciopen.com/article/10.26599/POM.2024.9140074
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589871319875584
author Shan Lei
Bingnian Chen
Li Wang
Jian Li
author_facet Shan Lei
Bingnian Chen
Li Wang
Jian Li
author_sort Shan Lei
collection DOAJ
description In recent years, polyoxometalates (POMs) have been extensively researched for their potential in treating diabetes, tumors, cancer, inflammation, and other diseases, both in vitro and in vivo. Their primary therapeutic mechanisms are related to the generation of reactive oxygen species (ROS), leading to oxidative stress. Because mitochondria are the main site of ROS production, POM treatment mechanisms may be associated with mitochondrial biosynthesis. This study explores one of the mechanisms by which POMs impact diabetes mellitus, focusing on the increase in ROS and the resulting oxidative stress. Additionally, POMs have been preliminarily studied for their antioxidant and antitumor properties in the treatment of diabetes mellitus and tumors. The antioxidant and antitumor properties of POMs are promising for future therapeutic drugs. By examining oxidative stress and its impact on various biomolecules, POMs have been recognized as a drug therapy mechanism closely linked to mitochondria. Investigating the relationship between POMs and mitochondrial biosynthesis, as well as their impact on mitochondria, provides a basis for future in-depth studies on the role of POMs in treating tumors, diabetes, and other diseases.
format Article
id doaj-art-cdfb6c5d659f459a9ca5acdb1898f86e
institution Kabale University
issn 2957-9821
2957-9503
language English
publishDate 2025-03-01
publisher Tsinghua University Press
record_format Article
series Polyoxometalates
spelling doaj-art-cdfb6c5d659f459a9ca5acdb1898f86e2025-01-24T08:12:25ZengTsinghua University PressPolyoxometalates2957-98212957-95032025-03-0141914007410.26599/POM.2024.9140074Study on the regulatory mechanisms of mitochondrial biosynthesis by polyoxometalatesShan Lei0Bingnian Chen1Li Wang2Jian Li3College of Ocean Food and Bioengineering, Jimei University, Xiamen 361021, ChinaXiang’an Hospital of Xiamen University, Xiamen 361021, ChinaCollege of Ocean Food and Bioengineering, Jimei University, Xiamen 361021, ChinaCollege of Ocean Food and Bioengineering, Jimei University, Xiamen 361021, ChinaIn recent years, polyoxometalates (POMs) have been extensively researched for their potential in treating diabetes, tumors, cancer, inflammation, and other diseases, both in vitro and in vivo. Their primary therapeutic mechanisms are related to the generation of reactive oxygen species (ROS), leading to oxidative stress. Because mitochondria are the main site of ROS production, POM treatment mechanisms may be associated with mitochondrial biosynthesis. This study explores one of the mechanisms by which POMs impact diabetes mellitus, focusing on the increase in ROS and the resulting oxidative stress. Additionally, POMs have been preliminarily studied for their antioxidant and antitumor properties in the treatment of diabetes mellitus and tumors. The antioxidant and antitumor properties of POMs are promising for future therapeutic drugs. By examining oxidative stress and its impact on various biomolecules, POMs have been recognized as a drug therapy mechanism closely linked to mitochondria. Investigating the relationship between POMs and mitochondrial biosynthesis, as well as their impact on mitochondria, provides a basis for future in-depth studies on the role of POMs in treating tumors, diabetes, and other diseases.https://www.sciopen.com/article/10.26599/POM.2024.9140074polyoxometalatesmitochondrialantioxidantantidiabeticantitumor
spellingShingle Shan Lei
Bingnian Chen
Li Wang
Jian Li
Study on the regulatory mechanisms of mitochondrial biosynthesis by polyoxometalates
Polyoxometalates
polyoxometalates
mitochondrial
antioxidant
antidiabetic
antitumor
title Study on the regulatory mechanisms of mitochondrial biosynthesis by polyoxometalates
title_full Study on the regulatory mechanisms of mitochondrial biosynthesis by polyoxometalates
title_fullStr Study on the regulatory mechanisms of mitochondrial biosynthesis by polyoxometalates
title_full_unstemmed Study on the regulatory mechanisms of mitochondrial biosynthesis by polyoxometalates
title_short Study on the regulatory mechanisms of mitochondrial biosynthesis by polyoxometalates
title_sort study on the regulatory mechanisms of mitochondrial biosynthesis by polyoxometalates
topic polyoxometalates
mitochondrial
antioxidant
antidiabetic
antitumor
url https://www.sciopen.com/article/10.26599/POM.2024.9140074
work_keys_str_mv AT shanlei studyontheregulatorymechanismsofmitochondrialbiosynthesisbypolyoxometalates
AT bingnianchen studyontheregulatorymechanismsofmitochondrialbiosynthesisbypolyoxometalates
AT liwang studyontheregulatorymechanismsofmitochondrialbiosynthesisbypolyoxometalates
AT jianli studyontheregulatorymechanismsofmitochondrialbiosynthesisbypolyoxometalates